Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B cell activation pathway refers to the series of molecular and cellular events that occur when a B lymphocyte (B cell) encounters an antigen, leading to its activation, proliferation, and differentiation into antibody-secreting plasma cells or memory B cells. This process is central to the adaptive immune response. It involves the B cell receptor (BCR), co-receptors, and various signaling molecules like kinases (Lyn, Syk, Btk) and adaptor proteins (BLNK) to transduce signals upon antigen binding, leading to downstream effects like proliferation, class-switch recombination, somatic hypermutation, and differentiation into plasma or memory B cells.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B Cell Activation Pathway (N/A).